CSII Insider Trading Activity and SEC Form 4 Filings
CSII insider trading summary
No open-market insider purchases or sales of Cardiovascular Systems Inc (CSII) have been reported on SEC Form 4 in the past 12 months.
Latest CSII insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 20, 2022 | Scott R. Ward | Chairman and CEO | Buy | $43K (3,000 @ $14.49) |
| May 20, 2022 | Jeffrey S. Points | Chief Financial Officer | Buy | $43K (3,000 @ $14.50) |
| Feb 23, 2022 | Erik Paulsen | Director | Buy | $10K (500 @ $19.05) |
| Feb 8, 2022 | Jeffrey S. Points | Chief Financial Officer | Buy | $36K (2,000 @ $18.20) |
| Feb 7, 2022 | Scott R. Ward | Chairman and CEO | Buy | $46K (2,500 @ $18.52) |
| Feb 7, 2022 | Martha Goldberg Aronson | Director | Buy | $46K (2,500 @ $18.43) |
| Feb 7, 2022 | Rhonda J. Robb | Chief Operating Officer | Buy | $29K (1,567 @ $18.71) |
| May 10, 2021 | Jeffrey S. Points | Chief Financial Officer | Buy | $34K (1,000 @ $34.20) |
| May 10, 2021 | Scott R. Ward | Chairman and CEO | Buy | $34K (1,000 @ $34.41) |
| May 10, 2021 | Martha Goldberg Aronson | Director | Buy | $52K (1,500 @ $34.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.